Injectable PLGA Microspheres with GES + EE
- User: Female
- Hormonal: Hormonal
-
Delivery type:
- Injectable
-
Intended Duration:
- Short-Acting
- Development Stage: Pre-Clinical
- Developer(s)/researcher(s): Peking University
Details
- API: Gestodene, Ethinylestradiol
- Target: Progesterone Receptor
-
Mechanism of Action:
- Ovulation Inhibition
- Cervical Mucus Changes
- Endometrial Changes
- Inactive Materials: PLGA
- Regimen: Undetermined
- MPT: Not Potential MPT
Product Status
No Indication of Development after 2008. GES + EE combination has been evaluated by other entities in non-microsphere delivery system
History
2008: Peking University published preclinical results indicating the viability of a microsphere-based injectable loaded with GES and EE